Dynacure
Manufacturing · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
850 Blvd Sébastien Brant, Illkirch-Graff...Phone Number
+33 374952050Website
www.dynacure.comRevenue
<$5 MillionIndustry
About Dynacure
Is Dynacure your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Dynacure has new funding data
Click to see if Dynacure had a recent Job posting/layoffs
Earning: See what the market has to say on Dynacure recently announced quarterly report
Check out if Dynacure is spiking on competitors!
Check if Dynacure has recently received funding, and reach out quickly before it becomes old news!
Dynacure, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Dynacure
Product Launch: Get notified when Dynacure launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Dynacure is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Dynacure is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Dynacure.
Dynacure financials insights
Gather financial insights about Dynacure, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$55M
Series C
$55M
Dynacure Tech Stack
A closer look at the technologies used by Dynacure
Most Recent Scoops
Dynacure News & Media
Dynacure Receives Fast Track Designation for DYN101, an Investigational Antisense Oligonucleotide for the Treatment of Myotubular and Centronuclear Myopathies
STRASBOURG, Pa., Jan. 6, 2022 /PRNewswire/ -- Dynacure, a clinical stage biotechnology company focusing on Myotubular and Centronuclear Myopathies (CNM), a group of rare, debilitating, and life-threatening genetic diseases, today announced that the U.S. Food and Drug Administration (FDA)...Dynacure to Present at 40th Annual J.P. Morgan Healthcare Conference
STRASBOURG, France and PHILADELPHIA, Jan. 3, 2022 /PRNewswire/ -- Dynacure, a clinical stage biotechnology company focusing on Myotubular and Centronuclear Myopathies (CNM), a group of rare, debilitating and life-threatening genetic diseases, today announced that Stephane van Rooijen, M.D....Dynacure Announces Strategic Collaboration and Option Agreement with Nippon Shinyaku
STRASBOURG, France and PHILADELPHIA and KYOTO, Nov. 10, 2021 /PRNewswire/ -- Dynacure, a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options, announced today that...Dynacure to Present Preclinical Data on Disease Progression Modelling and ASO-Mediated Dynamin 2 Knockdown at World Muscle Society (WMS) Meeting
STRASBOURG, France and PHILADELPHIA, Sept. 16, 2021 /PRNewswire/ -- Dynacure, a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options, will present three posters at...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Dynacure
Founded in 2016, Dynacure is a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options.... Read More